62501-73-9

Basic information

• Product Name: 1,4-Benzodioxin-2-methanol, 2,3-dihydro-, 4-methylbenzenesulfonate, (2S)-
• CAS NO: 62501-73-9
• Molecular Formula: C16H16O5S
• Molecular Weight: 320.366
• Mol File: 62501-73-9.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: 1,4-Benzodioxin-2-methanol, 2,3-dihydro-, 4-methylbenzenesulfonate, (2S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-Benzodioxin-2-methanol, 2,3-dihydro-, 4-methylbenzenesulfonate, (2S)-(62501-73-9)
• EPA Substance Registry System: 1,4-Benzodioxin-2-methanol, 2,3-dihydro-, 4-methylbenzenesulfonate, (2S)-(62501-73-9)

Safety Data

• Hazardous Substances Data: 62501-73-9(Hazardous Substances Data)

Upstream product

• 115563-61-6 (S)-1-(R)-2,3-Dihydro-benzo[1,4]dioxin-2-yl-2-propylamino-ethanol 
• 115563-60-5 (R)-1,4-benzodioxane-2-carboxaldehyde 
• 72522-21-5 (2R,1'S)-2-oxiranyl-1,4-benzodioxan 
• 164515-27-9 (2S)-1-(2'-benzyloxyphenoxy)-2-tosyloxy-3-benzyloxypropane 
• 164515-26-8 (2S)-1-(2'-benzyloxyphenoxy)-3-benzyloxy-2-propanol 
• 62501-71-7 (R)-2-benzyloxymethyl-2,3-dihydrobenzodioxane 
• 62501-72-8 (R)-2-hydroxymethyl-1,4-benzodioxane 
• 98-59-9 p-toluenesulfonyl chloride 
• 98572-00-0 (S)-2-hydroxymethyl-1,4-benzodioxane 

Downstream Products

• 81602-24-6 (R)-WB-4101 
• 46049-48-3 (R)-2-((amino)methyl)-1,4-benzodioxane 
• 115649-80-4 (-)-Spiroxatrine 

Relevant articles and documents

USE OF BENZO-FUSED HETEROCYLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF ANXIETY

The present invention is a method for the treatment of anxiety and related disorders comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I)

USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR DISEASE MODIFICATION / EPILEPTOGENESIS

The present invention is a method for treating, preventing, reversing, arresting or inhibiting the occurrence, development and maturation of seizures or seizure-related disorders. More specifically, the present invention is directed to methods for the use

USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR LOWERING LIPIDS AND LOWERING BLOOD GLUCOSE LEVELS

The present invention is a method for the glucose related disorders and lipid related disorders comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-fused heterocycle sulfamide derivatives of